Marshall Wace’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-18,623
Closed -$227K 3319
2025
Q3
$227K Buy
+18,623
New +$196K ﹤0.01% 2537
2024
Q3
Sell
-162,477
Closed -$1.71M 2825
2024
Q2
$1.71M Sell
162,477
-200,566
-55% -$2.54M ﹤0.01% 1449
2024
Q1
$5.02M Buy
363,043
+220,560
+155% +$3.44M 0.01% 997
2023
Q4
$2.77M Sell
142,483
-888,841
-86% -$16.4M ﹤0.01% 1097
2023
Q3
$21.9M Buy
1,031,324
+374,578
+57% +$9.74M 0.04% 408
2023
Q2
$21.8M Buy
+656,746
New +$24.2M 0.04% 451
2023
Q1
Sell
-17,189
Closed -$725K 2970
2022
Q4
$725K Sell
17,189
-278
-2% -$10.7K ﹤0.01% 2216
2022
Q3
$582K Buy
17,467
+3,701
+27% +$154K ﹤0.01% 2657
2022
Q2
$596K Buy
+13,766
New +$632K ﹤0.01% 2715
2021
Q4
Sell
-10,582
Closed -$428K 4166
2021
Q3
$428K Buy
+10,582
New +$535K ﹤0.01% 2467
2020
Q2
Sell
-28,146
Closed -$615K 1834
2020
Q1
$615K Buy
28,146
+23,581
+517% +$710K 0.01% 927
2019
Q4
$187K Sell
4,565
-766
-14% -$31.3K ﹤0.01% 1356
2019
Q3
$227K Buy
+5,331
New +$224K ﹤0.01% 1265
2019
Q2
Sell
-11
Closed -$1K 1688
2019
Q1
$1K Buy
+11
New +$667 ﹤0.01% 1665
2017
Q4
Sell
-3,785
Closed -$231K 457
2017
Q3
$231K Buy
+3,785
New +$232K 0.01% 319

Other funds holding NUS

Marshall Wace's NUS Position: Q4 2025 in Review

Marshall Wace sold out of Nu Skin (NUS) in Q4 2025, closing a stake of 18,623 shares — an estimated $227K sold.

Marshall Wace first reported a position in NUS in Q3 2017 and held it in 15 quarters. The position peaked at $21.9M in Q3 2023. 187 funds tracked by Wall St. Rank hold NUS as of Q4 2025.

  • Marshall Wace reported no remaining Nu Skin position as of Q4 2025 after selling out during the quarter.
  • Marshall Wace sold 18,623 Nu Skin shares in Q4 2025, an estimated $227K.
  • Marshall Wace first reported a position in Nu Skin in Q3 2017 and held it in 15 quarters.
  • Marshall Wace's Nu Skin position peaked at $21.9M in Q3 2023.
  • 187 funds tracked by Wall St. Rank held Nu Skin as of Q4 2025.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.